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Antimicrobial resistance: a clear and present danger in Ghana 
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The World Antibiotic Awareness Week (WAAW) is ob-
served every year in November and is aimed at creating 
awareness of the increasing problem of antibiotic re-
sistance. The celebration is also to encourage best prac-
tices among the general public, health workers and policy 
makers to avoid the further emergence and spread of an-
tibiotic resistance. 
 
In 2014, the World Health Organisation’s report on An-
timicrobial Resistance (AMR) showed high levels of re-
sistance in all regions of the world.1 The  global impact 
of AMR remains unknown, however the European Cen-
ter for Disease Prevention and Control (ECDC) estimates 
that  AMR is responsible for some 25,000 deaths per year 
with 2.5 million extra hospital days in Europe.2 Globally 
an estimated  10 million deaths attributable to AMR is 
expected to occur by 2050, with 4 million of these occur-
ring in Africa.3 The current impact of AMR in Africa re-
mains unknown from lack of data, but there is evidence 
of a significant level of resistance to commonly pre-
scribed antibiotics.4  
 
Antimicrobial resistance, albeit a naturally occurring 
phenomenon, has been worsened as a result of inappro-
priate use of antibiotics in humans and animals. In 
Ghana, high rates of antibiotic use has been observed in 
humans and animals.5-8 Inappropriate use of antimicro-
bial is facilitated by the unavailability or the lack of im-
plementation of antibiotic prescribing guidelines, lack of 
diagnostic microbiology services as well as unregulated 
access to over the counter antimicrobials by the general 
populace.  
 
Within hospitals and clinics, the spread of AMR is facil-
itated by poor implementation of Infection Prevention 
and Control (IPC) practices. Despite the presence of a na-
tional IPC policy in Ghana,9 there are significant chal-
lenges with its implementation. For example out of ten 
hospitals surveyed recently only one had a full time in-
fection control nurse10 although WHO recommends one 
full time IPC worker per 250 hospital beds.11 Several hos-
pitals still struggle for access to hand hygiene supplies 
including running water, soap and alcohol hand rub.  
 
In Ghana, there are increasing reports community and 
hospital acquired infections caused by Extended Spec-
trum Beta Lactamase (ESBL) producing organisms like 
E. coli and Klebsiella sp.12,13 Anecdotal evidence also 
shows an increase in the incidence of carbapenem re-
sistant Acinetobacter sp and Pseudomonas sp infections 
in vulnerable patient populations like those in intensive 
care units.  
 
 
In a recent audit at the Medical Intensive Care Unit 
(MICU) at a Teaching Hospital, there was high resistance 
to gentamicin and ciprofloxacin among aetiological 
agents of severe sepsis, with 100% resistance to 3rd gen-
eration cephalosporins (unpublished work, Yaw Ofori-
Adjei).   
 
It is obvious that urgent strategies are needed for the con-
trol of AMR in Ghana. These strategies should include 
improving access to diagnostic microbiology services, 
improving knowledge of prescribers by incorporating 
AMR into educational curricula of healthcare institutions 
as well as continuous medical education of healthcare 
practitioners. There is the need set up surveillance of 
AMR at all levels of healthcare nationwide, adequately 
implement IPC protocols in hospitals, train more Clinical 
Microbiologists and Infection prevention staff to increase 
and maintain focus on AMR and IPC in hospitals. Mean-
while there is the urgent need to embrace antibiotic stew-
ardship programs to protect the few potent antimicrobials 
available on the local market. Also, there is the need to 
improve access to alternative agents for treating multi-
drug resistant infections to reduce the increasing morbid-
ity and mortality from these organisms.  
 
The presence of a national Infection control and AMR 
policies shows the existence of the necessary political 
will towards combatting the problem of AMR in 
Ghana.9,14 A concerted effort is however needed to ensure 
that both policies are implemented at all levels in our 
health care delivery system including the private sector.   
 
This year’s WAAW was observed from the 12 – 18 of 
November. The WHO is encouraging the incorporation 
of two key messages to help guide the discussion on an-
tibiotic use and take steps towards wider public under-
standing of antibiotic resistance. They are “Think twice. 
Seek Advice.”  and “Misuse of Antibiotics puts us all at 
Risk”. As prescribers, we do need to question our deci-
sions to prescribe and rethink our choices of antibiotics. 
The antibiotics we have in our armament to combat re-
sistant strains have limited accessibility to the average 
patient due to cost and availability.  We must therefore 
ensure that we are all poised to stop the development 
AMR. Failure to do these places all of us at risk. 
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